ANKRD26 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.274000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.831600E-01
Normal-vs-Stage2
3.154400E-01
Normal-vs-Stage3
3.887500E-02
Normal-vs-Stage4
9.329600E-01
Stage1-vs-Stage2
2.696800E-01
Stage1-vs-Stage3
1.464830E-01
Stage1-vs-Stage4
8.130400E-01
Stage2-vs-Stage3
2.619400E-01
Stage2-vs-Stage4
2.020200E-01
Stage3-vs-Stage4
7.171800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.711400E-01
Normal-vs-AfricanAmerican
3.686200E-01
Normal-vs-Asian
3.622200E-02
Caucasian-vs-AfricanAmerican
9.286600E-01
Caucasian-vs-Asian
5.950000E-02
AfricanAmerican-vs-Asian
1.781160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.808800E-01
Normal-vs-Female
4.018800E-01
Male-vs-Female
5.797000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.676600E-01
Normal-vs-Age(41-60Yrs)
6.158800E-01
Normal-vs-Age(61-80Yrs)
2.228400E-01
Normal-vs-Age(81-100Yrs)
2.781400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.960000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.068000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.454200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.774440E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.499800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.512200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.454840E-01
Normal-vs-Daily Drinker
9.817900E-02
Normal-vs-Weekly Drinker
1.642640E-01
Normal-vs-Occasional Drinker
3.382800E-01
Normal-vs-Social Drinker
7.960400E-01
Non Drinker-vs-Daily Drinker
7.173600E-01
Non Drinker-vs-Weekly Drinker
7.984600E-01
Non Drinker-vs-Occasional Drinker
4.803800E-01
Non Drinker-vs-Social Drinker
2.396400E-01
Daily Drinker-vs-Weekly Drinker
5.687800E-01
Daily Drinker-vs-Occasional Drinker
3.279800E-01
Daily Drinker-vs-Social Drinker
1.781230E-01
Weekly Drinker-vs-Occasional Drinker
6.971800E-01
Weekly Drinker-vs-Social Drinker
3.214200E-01
Occasional Drinker-vs-Social Drinker
4.566000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.761810E-01
Normal-vs-Grade 2
1.306370E-01
Normal-vs-Grade 3
8.010500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.963200E-01
Grade 1-vs-Grade 3
1.774200E-01
Grade 1-vs-Grade 4
1.761810E-01
Grade 2-vs-Grade 3
5.040400E-01
Grade 2-vs-Grade 4
1.306370E-01
Grade 3-vs-Grade 4
8.010500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.582350E-01
Normal-vs-NonDiabetic
1.746190E-01
Diabetic-vs-NonDiabetic
8.162400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.683630E-01
Normal-vs-NoPancreatitis
1.902190E-01
Pancreatitis-vs-NoPancreatitis
8.698200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.103600E-01
Normal-vs-N1
3.054800E-01
N0-vs-N1
8.852000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.389000E-01
Normal-vs-TP53-NonMutant
7.577200E-01
TP53-Mutant-vs-TP53-NonMutant
1.139590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
